STZMEDIUM SIGNALFINANCIAL10-K

STZ shows declining operational performance with revenue down 10.5% and operating cash flow down 15.3%, but maintains strong balance sheet improvement with stockholders' equity up 17.4% and current liabilities reduced by 33.3%.

The company appears to be in a transition period with reduced operational scale but improved financial positioning, suggesting either strategic restructuring or market headwinds impacting core business performance. The significant reduction in current liabilities combined with stronger equity position indicates better financial flexibility, though investors should monitor whether the revenue decline represents temporary challenges or structural issues.

Comparing 2025-04-23 vs 2024-04-23View on EDGAR →
FINANCIAL ANALYSIS

STZ experienced broad-based declines in operational metrics with revenue falling 10.5% to $9.1B, gross profit down 11.3% to $4.7B, and operating cash flow decreasing 15.3% to $2.7B, while capital expenditures were reduced 27.9% to $875M. However, the balance sheet strengthened significantly with stockholders' equity rising 17.4% to $8.1B and current liabilities falling 33.3% to $2.7B, creating a more conservative financial structure. The overall picture suggests a company managing through operational challenges while maintaining strong financial discipline and balance sheet health.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+50.4%
$68.1M→$102.4M

Cash position surged 50.4% — strong cash generation or capital raise providing significant financial cushion.

Current Liabilities
Balance Sheet
-33.3%
$4.0B→$2.7B

Current liabilities reduced — improved short-term financial position and working capital health.

Capital Expenditure
Cash Flow
-27.9%
$1.2B→$875.0M

Capex reduced 27.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Assets
Balance Sheet
-21.8%
$3.7B→$2.9B

Current assets declined 21.8% — monitor working capital adequacy and short-term liquidity.

Share Buybacks
Cash Flow
-17.8%
$1.1B→$924.1M

Buyback activity reduced 17.8% — capital being redeployed elsewhere or cash conservation underway.

Stockholders Equity
Balance Sheet
+17.4%
$6.9B→$8.1B

Equity base grew 17.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Operating Cash Flow
Cash Flow
-15.3%
$3.2B→$2.7B

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Gross Profit
P&L
-11.3%
$5.3B→$4.7B

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Revenue
P&L
-10.5%
$10.2B→$9.1B

Revenue softened 10.5% — monitor whether this is cyclical or structural.

LANGUAGE CHANGES
NEW — 2025-04-23
PRIOR — 2024-04-23
ADDED
Form 10-K Summary 109 INDEX TO EXHIBITS 110 SIGNATURES 115 Market positions and industry data discussed in this Form 10-K are as of calendar 2024 and have been obtained or derived from industry and government publications and our estimates.
Management s Discussion and Analysis of Financial Condition and Results of Operations regarding: upholding our leadership position in the U.S.
and retaliatory tariffs imposed on certain product imports originating from the U.S.; expected or potential actions of third parties, including possible changes to laws, rules, and regulations; the potential impact of severe weather events or other weather conditions; the manner, timing, and duration of the share repurchase program and source of funds for share repurchases; the amount and timing of future dividends; and the statements regarding the impacts of recent accounting pronouncements.
The statements regarding the future reclassification of net gains from AOCI.
GAAP, for example, comparable operating income (loss) Note(s) notes to the consolidated financial statements under Item 8.
+7 more — sign up free →
REMOVED
Form 10-K Summary 114 INDEX TO EXHIBITS 115 SIGNATURES 120 Market positions and industry data discussed in this Form 10-K are as of calendar 2023 and have been obtained or derived from industry and government publications and our estimates.
The statements regarding the impacts of recent accounting pronouncements; The statements regarding our future accounting treatment for our investment in Canopy, including the expected gain related to the conversion of our Canopy common shares into Exchangeable Shares and exchange of the 2023 Canopy Promissory Note for Exchangeable Shares; and The statements regarding the future reclassification of net gains from AOCI.
In addition to the risks and uncertainties of ordinary business operations and conditions in the general economy and markets in which we Constellation Brands, Inc.
of this Form 10-K November 2018 Canopy Warrants warrants acquired in November 2018 which gave us the option to purchase common shares of Canopy, now expired NPD new product development Obregon Obregon, Sonora, Mexico Obregon Brewery brewery located in Obregon OCI other comprehensive income (loss) Constellation Brands, Inc.
Veracruz Heroica Veracruz, Veracruz, Mexico Veracruz Brewery a new brewery being constructed in Veracruz WildStar WildStar Partners LLC Wine Divestiture sale of certain mainstream and premium wine brands and related inventory Constellation Brands, Inc.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →